Get my own profile
Public access
View all8 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Michael HaydenKillam Professor, University of British ColumbiaVerified email at cmmt.ubc.ca
- Sarah KolitzImmuneeringVerified email at immuneering.com
- Rebecca KuskoCellinoVerified email at cellinobio.com
- Fadi TowficPrometheus BiosciencesVerified email at prometheusbiosciences.com
- Donna G. CrenshawDuke UniversityVerified email at duke.edu
- Yoonjeong ChaMITVerified email at mit.edu
- David B. GoldsteinColumbia UniversityVerified email at columbia.edu
- S PapapetropoulosConsultant, Massachusetts General Hospital, Department of NeurologyVerified email at mgh.harvard.edu
- Ariel MillerProf. of Medicine (Neurology), Carmel Medical Center & Technion, Haifa, IsraelVerified email at tx.technion.ac.il
- Jacques S BeckmannProf emeritus, UNILVerified email at unil.ch
- Dr. Jermaine RossAlleo LabsVerified email at alleolabs.com
- Doron LancetProfessor, Dept. Molecular Genetics, Weizmann Institute of Science, Rehovot, IsraelVerified email at weizmann.ac.il
- Brian WeinerSeres TherapeuticsVerified email at serestherapeutics.com
- William K GottschalkDuke UniversityVerified email at Duke.edu
- Ian ReynoldsYaghPenn Consulting BVVerified email at yaghpenn.com
- Jason FuntImmuneering CorporationVerified email at alum.mit.edu
- David MatcharProfessor of Medicine, Duke UniversityVerified email at duke-nus.edu.sg
- Ignacio S. CaballeroBoston UniversityVerified email at bu.edu
- Joel KayePharmacology Project Leader, Teva Pharmaceutical Industries LtdVerified email at teva.co.il
- Ornit Chiba-FalekProfessor of Neurology and Pathology, Duke University School of MedicineVerified email at duke.edu